or Try an Advanced Search...

    Holdings

    Symbol Grade Price % Change Allocation
    NVO F 0.00 1.72
    NVS D 0.00 0.95

    Represented by ETF Holdings

    Keywords: Active Pharmaceutical Ingredients Animal Health Anti Diabetic Drugs Antibiotics Biopharmaceutical Biotechnology Blood Test Contact Lens Contact Lenses Diabetes Diabetes Care Diagnostic Products Disposable Product Disposable Products Drugs Endocrine System Eye Eye Care Eye Care Products Eyewear
    Industries: Biotechnology Drug Manufacturers - Major

    Recent News for WisdomTree International Efficient Core Fund & its Holdings

    Date Stock Title
    Oct 2 NVO European Equities Close Mostly Higher in Wednesday Trading; Euro Area Unemployment Unchanged in August
    Oct 2 NVO Eli Lilly Commits $4.5B To New Facility, Banking On Mounjaro, Zepbound's Weight Loss Success Despite Short-Term Stock Challenges
    Oct 2 NVS Here's Why You Should Add ALNY Stock to Your Portfolio Right Now
    Oct 2 NVO Novo Nordisk Is Still a Buy, Analysts Say. Slowing Growth for Ozempic and Wegovy Isn’t a Problem.
    Oct 2 NVO Eli Lilly Invests $4.5B In New Medicine Foundry for Advanced Drug Manufacturing To Push US Pharma Boundaries
    Oct 2 NVO Eli Lilly Nears First Trillion Pharma Title, But Investors Caution Amid Sky-High Valuation
    Oct 2 NVO Weight loss drug breakthroughs, gene therapies, and more: 8 clinical trials to watch right now
    Oct 1 NVO Novo Nordisk (NVO) Stock Moves -0.89%: What You Should Know
    Oct 1 NVO U.S. port strike expected to have limited impact on healthcare supply chain: HHS
    Oct 1 NVS US HHS Reveal Cost Savings For 54 Prescription Drugs Including Novartis' Cancer Drug, Ozempic Could be Next
    Oct 1 NVO Novo Nordisk has mitigation plans to minimize disruption from port strikes, CNBC reports
    Oct 1 NVS Teva launches first U.S. generic against Novartis antidiarrheal Sandostatin LAR
    Sep 30 NVS Top Research Reports for Apple, Tesla & T-Mobile US
    Sep 30 NVS Novartis: Value Continues To Build With Double-Digit Percentage Growth Products
    Sep 30 NVO Novo Nordisk (NVO) Poised for 23.3% Upside as Obesity Market Expands and Clinical Trials Impress
    Sep 30 NVO Is Novo Nordisk A/S (NYSE:NVO) The Top Global Stock To Buy Now?
    Sep 30 NVS Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Medical Names
    Sep 29 NVO Novo Nordisk's Ozempic, Regeneron/Sanofi's Dupixent set to advance in top drug sales
    Sep 29 NVO 'Stop Ripping Us Off' – Incredibly, Elon Musk And Bernie Sanders Seem To Agree On This One Thing – 'I Really Am With Bernie On This One'
    Sep 28 NVO 15 Unhealthiest Countries in Europe
    WisdomTree International Efficient Core Fund is an exchange-traded fund incorporated in the US. The Fund is actively managed using a models-based approach. The fund seeks to achieve its investment objective by investing in International equity securities and U.S. Treasury futures contracts
    Exchange Traded Fund Index Fund Investment Management U.S. Treasury Passive Management Wisdomtree Investments Efficient Core Fund
    Back to the Main NTSI Page...